Practice Expertise
- Financial Services
- Healthcare & Life Sciences
- Industry & Commerce
- Arbitration
Areas of Practice
- Arbitration
- Financial Services
- Healthcare & Life Sciences
- Industry & Commerce
- Litigation View More
Profile
Benjamin Suter is counsel at Walder Wyss. He advises and represents clients in disputes in pre-litigation phases as well as before state courts, arbitral tribunals and public authorities. His practice as a litigator encompasses all areas of business law.
Born in 1982, Benjamin Suter studied at the University of Basel (lic.iur., 2008) and at Victoria University of Wellington (LL.M., 2014). He worked as a trainee in the Department of Education, Culture and Sports and at the Court of Appeal of the canton of Basel-Landschaft. Prior to joining Walder Wyss, he had been working for a leading Swiss law firm in Basel for several years.
Benjamin Suter practices in German and English and speaks French. He is registered with the bar registry of the canton of Basel-Stadt and is admitted to practice in all of Switzerland.
Born in 1982, Benjamin Suter studied at the University of Basel (lic.iur., 2008) and at Victoria University of Wellington (LL.M., 2014). He worked as a trainee in the Department of Education, Culture and Sports and at the Court of Appeal of the canton of Basel-Landschaft. Prior to joining Walder Wyss, he had been working for a leading Swiss law firm in Basel for several years.
Benjamin Suter practices in German and English and speaks French. He is registered with the bar registry of the canton of Basel-Stadt and is admitted to practice in all of Switzerland.
Areas of Practice
- Arbitration
- Financial Services
- Healthcare & Life Sciences
- Industry & Commerce
- Litigation
Professional Career
Significant Accomplishments
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round
SkyCell AG - USD 57m financing round
Chambers and Partners has moved Walder Wyss’s Arbitration Team up to Band 2 in its 2023 Global Ranking
Avery Dennison acquires TexTrace
Beförderungen bei Walder Wyss
Beförderungen bei Walder Wyss
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round
SkyCell AG - USD 57m financing round
Chambers and Partners has moved Walder Wyss’s Arbitration Team up to Band 2 in its 2023 Global Ranking
Avery Dennison acquires TexTrace
Beförderungen bei Walder Wyss
Beförderungen bei Walder Wyss
